AbCellera Biologics Inc
ABCL
Market Cap$1.08B
Close$
$-2.38
168.3% downside
Current Fair Value
168.3% downsideOvervalued by 168.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.08 Billion |
|---|---|
| Enterprise Value | $1.00 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.55 |
| Beta | 0.36 |
| Outstanding Shares | 297,692,663 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.4 |
|---|---|
| PEG | -51.88 |
| Price to Sales | - |
| Price to Book Ratio | 3.49 |
| Enterprise Value to Revenue | 43.27 |
| Enterprise Value to EBIT | -3.7 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
ESG Score
No data